Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.11
13.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Shenzhen Hepalink Pharmaceutical Group Co Ltd stock under the Base Case scenario is 16.16 CNY. Compared to the current market price of 12.13 CNY, Shenzhen Hepalink Pharmaceutical Group Co Ltd is Undervalued by 25%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Shenzhen Hepalink Pharmaceutical Group Co Ltd.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Balance Sheet Decomposition
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Free Cash Flow Analysis
Shenzhen Hepalink Pharmaceutical Group Co Ltd
| CNY | |
| Free Cash Flow | CNY |
Earnings Waterfall
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Profitability Score
Profitability Due Diligence
Score
Solvency Score
Solvency Due Diligence
Score
Wall St
Price Targets
Price Targets Summary
Shenzhen Hepalink Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Shenzhen Hepalink Pharmaceutical Group Co Ltd is 9.18 CNY with a low forecast of 9.09 CNY and a high forecast of 9.45 CNY.
Dividends
Current shareholder yield for Shenzhen Hepalink Pharmaceutical Group Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Shenzhen Hepalink Pharmaceutical Group Co Ltd stock under the Base Case scenario is 16.16 CNY.
Compared to the current market price of 12.13 CNY, Shenzhen Hepalink Pharmaceutical Group Co Ltd is Undervalued by 25%.